Surge in Cardiac Ablation Procedures to Treat Atrial Fibrillation Fuels Total CRM Market to Over $8 Billion
CRM, Electrophysiology and Ablation Market to Reach Over
Increased incidence of cardiac disease and improved diagnostic technology will drive growth in cardiac ablation and electrophysiology procedures, the combined markets for which are expected to reach over
Heart failure afflicts nearly 5 million Americans and is the most costly cardiovascular illness, with an estimated
“The fastest growing market segments in the CRM, electrophysiology and ablation market are expected to be CRTs, ICDs and diagnostic electrophysiology catheters,” says Dr.
The report also states that companies such as Bard (NYSE: BCR), Biosense Webster, Cardiac Science (NASDAQ: CSCX), Medtronic (NYSE: MDT), Philips, St. Jude Medical and Zoll lead the market, among many others.
iData’s global 3-report series on the “Markets for CRM, Electrophysiology and Ablation Devices 2010″ covers pacemakers, CRTs, ICDs, cardiac stimulation leads, external-defibrillators, ablation and EP catheters, electrophysiology stimulators and cardiac monitoring devices.
For more information, register free on iData’s website at: http://www.idataresearch.net/idata/registration.php
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: CRM, peripheral vascular, interventional cardiology, vascular access, cardiac surgery, pharmaceuticals and more.
SOURCE iData Research Inc.